FR Doc E8-17977[Federal Register: August 6, 2008 (Volume 73,
Number 152)] [Notices] [Page 45780] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06au08-84]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21
U.S.C. 952(a)(2) authorizing the importation of such a
substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 Code of Federal
Regulations (CFR), 1301.34(a), this is notice that on June 2,
2008, Wildlife Laboratories, 1401 Duff Drive, Suite 400, Fort
Collins, Colorado 80524, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer
of Etorphine Hydrochloride (9059), a basic class of controlled
substance listed in schedule II. The company plans to import the
listed controlled substance for sale to its customers.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of
controlled substance may file comments or objections to the
issuance of the proposed registration and may, at the same time,
file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or objections should be addressed,
in quintuplicate, to the Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be
filed no later than September 5, 2008.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a
previous notice published in the Federal Register on September
23, 1975, (40 FR 43745), all applicants for registration to
import a basic class of any controlled substance listed in
schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the
requirements for such registration pursuant to 21 U.S.C. 958(a),
21
U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e), and (f)
are satisfied.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-17977 Filed 8-4-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).